CPX-351 as a Novel Approach for the Treatment of Older Patients With AML and MDS

Clinical trial NCT04668885 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04668885
Sponsor: Case Comprehensive Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Refractory Acute Myeloid Leukemia Relapsed Acute Myelomonocytic Leukemia Myelodysplastic Syndromes

Start date: 2021-01-14
Primary completion: 2026-01-19
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.